TWF1 and B-cell acute lymphoblastic leukemia: For example, Kim et al. systemically demonstrated integrin α4 and α6 mediated drug resistance in B-cell acute lymphoblastic leukemia, and either integrin α4 or α6 inhibition led to increased chemosensitivity (166–168).